[go: up one dir, main page]

ATE231129T1 - Pharmazeutische pyridin-derivate - Google Patents

Pharmazeutische pyridin-derivate

Info

Publication number
ATE231129T1
ATE231129T1 AT93915498T AT93915498T ATE231129T1 AT E231129 T1 ATE231129 T1 AT E231129T1 AT 93915498 T AT93915498 T AT 93915498T AT 93915498 T AT93915498 T AT 93915498T AT E231129 T1 ATE231129 T1 AT E231129T1
Authority
AT
Austria
Prior art keywords
pharmaceutical
pyridine derivatives
pct
sec
date jun
Prior art date
Application number
AT93915498T
Other languages
English (en)
Inventor
Robert A Daines
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Application granted granted Critical
Publication of ATE231129T1 publication Critical patent/ATE231129T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/65One oxygen atom attached in position 3 or 5
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT93915498T 1992-06-30 1993-06-30 Pharmazeutische pyridin-derivate ATE231129T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US90677192A 1992-06-30 1992-06-30
US2519893A 1993-03-02 1993-03-02
PCT/US1993/006234 WO1994000437A1 (en) 1992-06-30 1993-06-30 Pharmaceutical pyridine compounds

Publications (1)

Publication Number Publication Date
ATE231129T1 true ATE231129T1 (de) 2003-02-15

Family

ID=26699422

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93915498T ATE231129T1 (de) 1992-06-30 1993-06-30 Pharmazeutische pyridin-derivate

Country Status (16)

Country Link
US (1) US5990314A (de)
EP (1) EP0649412B1 (de)
JP (1) JP3230682B2 (de)
KR (1) KR950702185A (de)
CN (1) CN1108247A (de)
AT (1) ATE231129T1 (de)
AU (2) AU4545893A (de)
CA (1) CA2138954A1 (de)
DE (1) DE69332640T2 (de)
ES (1) ES2191014T3 (de)
IL (1) IL106156A0 (de)
MA (1) MA22926A1 (de)
MX (1) MX9303973A (de)
NZ (1) NZ253967A (de)
SI (1) SI9300349A (de)
WO (1) WO1994000437A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0711282B1 (de) 1993-07-28 2002-06-05 Aventis Pharma Limited Verbindungen als pde iv und tnf inhibitoren
EP0733044A4 (de) * 1993-12-08 1997-03-05 Smithkline Beecham Corp Chemische verbindungen
NZ278484A (en) * 1993-12-09 1998-02-26 Smithkline Beecham Corp Diphenyl-2-propenoates and homologues; medicaments
DE69609820T2 (de) * 1995-03-02 2001-03-08 Smithkline Beecham Corp., King Of Prussia Verwendung von substituirten Pyridinverbindungen zur Behandlung der atopischen Dermatitis und der Kontaktdermatitis
GB9508137D0 (en) * 1995-04-21 1995-06-07 Smithkline Beecham Plc Formulation
GB9602675D0 (en) * 1996-02-09 1996-04-10 Smithkline Beecham Plc Process
US5929096A (en) * 1996-02-29 1999-07-27 Smithkline Beecham Corporation Method for treating atopic dermatitis and contact dermatitis
JP2001501202A (ja) * 1996-09-26 2001-01-30 ノバルティス アクチエンゲゼルシャフト ロイコトリエンb4(ltb―4)レセプターアンタゴニスト活性によるアリル置換アクリルアミド
US7361671B2 (en) * 2001-11-15 2008-04-22 The Institute For Pharmaceutical Discovery, Inc. Substituted heteroarylalkanoic acids

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991018601A1 (en) * 1990-06-07 1991-12-12 Smithkline Beecham Corporation Benzoic acid derivatives
JPH05507475A (ja) * 1990-06-07 1993-10-28 スミスクライン・ビーチャム・コーポレイション ロイコトリエン関連疾患治療用安息香酸誘導体
US5643914A (en) * 1993-03-02 1997-07-01 Smithkline Beecham Corporation Pharmaceutical pyridine compounds

Also Published As

Publication number Publication date
EP0649412B1 (de) 2003-01-15
EP0649412A1 (de) 1995-04-26
CA2138954A1 (en) 1994-01-06
EP0649412A4 (de) 1995-07-05
WO1994000437A1 (en) 1994-01-06
DE69332640T2 (de) 2003-11-06
AU4545893A (en) 1994-01-24
CN1108247A (zh) 1995-09-13
MX9303973A (es) 1994-04-29
DE69332640D1 (de) 2003-02-20
NZ253967A (en) 1996-11-26
ES2191014T3 (es) 2003-09-01
JP3230682B2 (ja) 2001-11-19
AU2280797A (en) 1997-08-14
AU707102B2 (en) 1999-07-01
IL106156A0 (en) 1993-10-20
MA22926A1 (fr) 1994-04-01
KR950702185A (ko) 1995-06-19
SI9300349A (sl) 1993-12-31
US5990314A (en) 1999-11-23
JPH07508284A (ja) 1995-09-14

Similar Documents

Publication Publication Date Title
DE59511017D1 (de) [a]-ANNELIERTE PYRROLDERIVATE UND DEREN ANWENDUNG IN DER PHARMAZIE
NO308794B1 (no) Farmakologisk aktive pyridin-derivater, preparater inneholdende forbindelsene samt forbindelsenes anvendelse
BR9106432A (pt) Indolona neuroprotetora e derivados correlatos
ES2154270T3 (es) Nuevos derivados del imidazol, su preparacion y sus aplicaciones terapeuticas.
EP0706373A4 (de) In liposomen verkapseltes taxol und verwendungsverfahren
ES2075202T3 (es) Nuevas arilpiridazinas, su preparacion, su utilizacion, y medicamentos que las contienen.
ATE126215T1 (de) Anti-entzündende 4-aminophenol-derivate.
ATE210147T1 (de) Glycokonjugate von modifizierten camptothecin- derivaten(a- oder b-ring-verknüpfung)
IT1256697B (it) Medicamenti per trattare condizioni infiammatorie o per analgesia.
MX9300779A (es) 3-(1h-tetrazol-5-y1)-4h-pyrido[1,2-a]pirimidina-4-onas composiciones farmaceuticas que las contienen y su preparacion de las mismas
EE9800318A (et) Leukotrieen-antagonistliku toimega bensopüraanderivaadid
ATE231129T1 (de) Pharmazeutische pyridin-derivate
FI973221A0 (fi) 1-aryyli-2-asyyliammo-etaaniyhdisteitä ja niiden käyttö neurokiniiniantagonisteina, erityisesti neurokiniini 1 antagonisteina
SE8701375D0 (sv) Novel pyridyl- and pyrimidyl derivatives
DE69412073D1 (de) Xanthinderivate als adenosin-a1 rezeptor antagonisten
ATE153336T1 (de) Verbrückte bis-aryl-carbinol-derivate, zusammensetzungen und ihre verwendung
DE69112573D1 (de) Immunstimulierendes arzneimittel, das polare glycopeptidolipide von mycobakterium-chelonae enthält.
FR2700166B1 (fr) Dérivés de pyrrolidine, leur préparation et les médicaments les contenant.
NO941084D0 (no) Neuroleptiske 2-substituerte perhydro-1-H-pyrido[1,2-aÅpyraziner
DE69606777D1 (de) Naphthamidderivate von 3-beta-amino azabicyclooctan oder nonan als antipsychotische arzneimittel
DE69705772D1 (de) Adamantyl substituierte Oxindole als pharmazeutische Wirkstoffe
FR2684992B1 (fr) Procede de preparation d'amino-2 nitro-7 benzothiazoles.
JO1519B1 (en) New compounds (new benzimidazole derivatives are effective as ulcers)
DE59609482D1 (de) Anellierte beta-carboline

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties